Written by Jason Napodano, CFA We view Aastrom Biosciences (NASDAQ:ASTM) at the premier play for the application of adult stem cells for potential cardiovascular indications.  While other stem cell companies such as Cytori Therapeutics (the market leader for cosmetic and reconstructive surgery) and Osiris Therapeutics (the market leader for inflammatory diseases) command higher market capitalizations, [...]